» Articles » PMID: 12785050

Photoaffinity Labeling of the N-methyltransferase Domains of Cyclosporin Synthetase

Overview
Date 2003 Jun 6
PMID 12785050
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

The multifunctional polypeptide cyclosporin synthetase (CySyn) remains one of the most complex nonribosomal peptide synthetase described. In this study we used a highly specific photoaffinity labeling procedure with the natural cofactor S-adenosyl-L-methionine (AdoMet), 14C-isotopically labeled at the Sdelta methyl group to probe the concerted AdoMet-binding interaction of the N-methyltransferase (N-MTase) centers of CySyn. The binding stoichiometry for the enzyme-AdoMet complex was determined to be 1:7, which is in agreement with inferences made from analysis of the complementary DNA sequence of the simA gene encoding the CySyn polypeptide. The photolabeling of the AdoMet-binding sites displayed homotropic negative cooperativity, characterized by a curvilinear Scatchard plot with upward concavity. Although, the process of N-methyl transfer is not a critical event for peptide elongation, the destabilizing homotropic interactions between N-MTase centers that were observed may represent a mechanism whereby the enzyme preserves the proficiency of the substrate-channeling process of cyclosporin peptide assembly over a broad range of cofactor concentrations. Furthermore, we demonstrated the utility of the photolabeling procedure for tracking the enzyme during purification.

Citing Articles

Structural complex of sterol 14α-demethylase (CYP51) with 14α-methylenecyclopropyl-Delta7-24, 25-dihydrolanosterol.

Hargrove T, Wawrzak Z, Liu J, Waterman M, Nes W, Lepesheva G J Lipid Res. 2011; 53(2):311-20.

PMID: 22135275 PMC: 3269163. DOI: 10.1194/jlr.M021865.


Photoaffinity labeling and mutational analysis of 24-C-sterol methyltransferase defines the AdoMet binding site.

Jayasimha P, Nes W Lipids. 2008; 43(8):681-93.

PMID: 18563465 DOI: 10.1007/s11745-008-3198-x.


Nonribosomal peptide synthetases involved in the production of medically relevant natural products.

Felnagle E, Jackson E, Chan Y, Podevels A, Berti A, McMahon M Mol Pharm. 2008; 5(2):191-211.

PMID: 18217713 PMC: 3131160. DOI: 10.1021/mp700137g.